Fertility preservation before and after cancer treatment in children, adolescents, and young adults
Cancer · 2024-02 · 130 (3) · 344-355
DOI: 10.1002/cncr.35108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 14.11.2023. Verfasst von Emily H Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms, Infertility, Genital Neoplasms, Female. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Fertility is a top concern for many survivors of cancer diagnosed as children, adolescents and young adults (CAYA). Fertility preservation (FP) treatments are effective, evidence‐based interventions to support their family building goals. Fertility discussions are a part of quality oncology care throughout the cancer care continuum. For nearly 2 decades, clinical guidelines recommend counseling patients about the possibility of infertility promptly at diagnosis and offering FP options and referrals as indicated. Multiple guidelines now recommend post‐treatment counseling. Infertility risks differ by cancer treatments and age, rendering risk stratification a central part of FP care. To support FP decision‐making, online tools for female risk estimation are available. At diagnosis, females can engage in mature oocyte/embryo cryopreservation, ovarian tissue cryopreservation, ovarian suppression with GnRH agonists, in vitro oocyte maturation, and/or conservative management for gynecologic cancers. Post‐treatment, several populations may consider undergoing oocyte/embryo cryopreservation. Male survivors’ standard of care FP treatments center on sperm cryopreservation before cancer treatment and do not have the same post‐treatment indication for additional gamete cryopreservation. In practice, FP care requires systemized processes to routinely screen for FP needs, bridge oncology referrals to fertility, offer timely fertility consultations and access to FP treatments, and support financial navigation. Sixteen US states passed laws requiring health insurers to provide insurance benefits for FP treatments, but variation among the laws and downstream implementation are barriers to accessing FP treatments. To preserve the reproductive futures of CAYA survivors, research is needed to improve risk stratification, FP options, and delivery of FP care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, La Jolla, California, USA.
- School of Medicine, University of California, San Diego, La Jolla, California, USA.
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Yang, E. H., Strohl, H. B., & Su, H. I. (2024). Fertility preservation before and after cancer treatment in children, adolescents, and young adults. Cancer, 130(3), 344-355. https://doi.org/10.1002/cncr.35108
Vancouver
Yang EH, Strohl HB, Su HI. Fertility preservation before and after cancer treatment in children, adolescents, and young adults. Cancer. 2024;130(3):344-355. doi:10.1002/cncr.35108
BibTeX
@article{Yang2024,
author = {Yang, Emily H and Strohl, Harmonie B and Su, H Irene},
title = {Fertility preservation before and after cancer treatment in children, adolescents, and young adults},
journal = {Cancer},
year = {2024},
volume = {130},
number = {3},
pages = {344--355},
doi = {10.1002/cncr.35108}
}
EUVIMED